HOME >> BIOLOGY >> NEWS
Engineers design new optical microprobe to detect subsurface organ abnormalities

DURHAM, N.C. -- Photonics and ultrasound engineering researchers from Duke University and The George Washington University have collaborated to design an optical scanner miniaturized enough to be inserted into the body, where its light beams could someday detect abnormalities hidden in the walls of the colon, bladder or esophagus.

The experimental device, called an "electrostatic micromachine scanning mirror for optical coherence tomography," is described in an article published in the April 15, 2003, issue of the research journal Optics Letters. Once approved for use in hospitals and clinics, it would provide a new capability for endoscopy procedures.

Using tiny electrically activated artificial muscle fibers to vibrate a goldcovered mirror only about 2 millimeters wide, the prototype device broadcasts a special kind of quasi-laser light that can not only scan internal organ surfaces but also penetrate just beneath the surface.

Key researchers in the miniaturization effort are Jason Zara, an assistant professor of engineering and applied science at George Washington, and Stephen Smith, a professor of biomedical engineering at Duke's Pratt School of Engineering in Durham, N.C.

"This new device has shown great promise for new diagnostic applications," said Zara, Smith's former graduate student at Duke who is lead author of the Optics Letter report. Co-authors include Smith; Joseph Izatt, an associate professor of biomedical engineering at Duke's Pratt School of Engineering; and Izatt's former graduate student Siavash Yazdanfar and former postdoctoral research associate K. Divakar Rao.

Izatt, who leads biophotonics research activities at the Pratt School's Fitzpatrick Center for Photonics and Communications Systems, is a leader in the budding optical scanning technology that Zara and Smith have scaled down to fit into catheters.

Zara and Smith designed and fabricated a system that includes a tiny mirror that vibrate
'"/>

Contact: Monte Basgall
monte.basgall@duke.edu
919-681-8057
Duke University
16-Apr-2003


Page: 1 2 3

Related biology news :

1. Engineers work on their SUNTANS as they track waves and beaches
2. Engineers develop odour eaters for pulp mills
3. Engineers develop technology to reduce industry emissions
4. NSF-Supported New Scientists And Engineers Receive Presidential Award
5. Penn State Engineers Develop New Simulation For Ultrafine Particle Growth Process
6. "Lab On A Chip" For DNA Testing Invented By U-M Engineers
7. U-M Engineers Win Army Grant To Build Artificial Eye
8. Virginia Tech Engineers Help Mother Nature Clean Up
9. Cellular Engineers Design Custom Cell Surfaces Able To Adhere To Synthetic Materials
10. Environmental Engineers Demonstrate Effective Method For Trapping Highway Pollutants
11. Learning From Birds And Bees: Engineers Study Insects For Ideas On Tiny "Micro Air Vehicles"

Post Your Comments:
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/21/2015)... 21, 2015 High crime ... are boosting access control systems market in ... a recently published report by TechSci Research " Saudi ... access control systems market in Saudi Arabia ... 2020.The access control systems market in the Kingdom is ...
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
(Date:5/22/2015)... 2015 Knowledgent , the data ... explores the potential of big data analytics in the ... developed to help life sciences and healthcare organizations understand ... gain critical business insights. , The life sciences and ... driven by patient profiling, compliance and regulatory requirements, and ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
Breaking Biology Technology:New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7
Cached News: